SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
155.00    2.20 (1.44%)
Bid:
154.80
Ask:
155.20
Spread: 0.40 (0.258%)
Market Cap: £887.09m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading Update

18 Jan 2022 07:00

RNS Number : 7365Y
Elementis PLC
18 January 2022
 

Elementis plc

Trading Update

FY 21 adjusted operating profit modestly ahead of expectations

Leverage reduction on track

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months and year ended 31 December 2021.

Business performance

 

The Group has delivered a good fourth quarter performance, with double-digit year-on-year underlying revenue growth, agile supply chain management and self-help actions. As a result, adjusted operating profit for 2021 is expected to be in the range of $105-107m, modestly ahead of expectations*.

 

· Coatings performed well in Q4, and ahead of the prior year. As a result of pricing actions and volume growth, the business will deliver improved operating margins versus 2020.

 

· Personal Care performance in Q4 improved on the prior year. Demand continued to recover in cosmetics, as social and travel restrictions begin to ease, albeit still at levels below 2019.

 

· Talc performance in Q4 was below prior year as semi-conductor supply shortages continued to reduce automotive related demand.

· Chromium performance improved on the prior year as strong industrial demand was supported by improved pricing trends as global industry capacity utilisation increased.

 

In the fourth quarter we have continued to successfully deliver our Innovation, Growth and Efficiency strategy. For the full year 2021 we launched over 20 new products, won more than $35m of new business and delivered $10m of in year cost savings.

Balance Sheet

 

Net debt (excluding lease liabilities) at the end of 2021 is anticipated to be approximately $400m, representing a leverage ratio of 2.6x net debt to EBITDA**, and a significant reduction compared to 3.2x reported at the 31 December 2020.

 

Full 2021 results will be released on 3 March 2022 at 7am (UK) and will be available via the Elementis Plc website.

 

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

Olivia Peters

 

* Based on company compiled consensus, the Board believes the average market forecast for 2021 adjusted operating profit to be $104m.

 

**Excluding IFRS 16 impact

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUPUGUPPGBM
Date   Source Headline
29th Nov 201311:00 amRNSTotal Voting Rights
31st Oct 201311:00 amRNSTotal Voting Rights
25th Oct 20137:00 amRNSInterim Management Statement
16th Oct 20131:00 pmRNSAdditional Listing
1st Oct 20139:00 amRNSDirectorate Change
30th Sep 201311:00 amRNSTotal Voting Rights
6th Sep 20131:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20134:00 pmRNSBlocklisting Interim Review
30th Aug 20131:00 pmRNSTotal Voting Rights
28th Aug 201311:00 amRNSDirector/PDMR Shareholding
23rd Aug 20134:30 pmRNSHolding(s) in Company
2nd Aug 20134:00 pmRNSHolding(s) in Company
31st Jul 20134:01 pmRNSHolding(s) in Company
31st Jul 20134:00 pmRNSDirector/PDMR Shareholding
31st Jul 20131:00 pmRNSTotal Voting Rights
30th Jul 20137:00 amRNSInterim Results
22nd Jul 20137:00 amRNSDirectorate Change
3rd Jul 201311:00 amRNSHolding(s) in Company
28th Jun 201312:42 pmRNSTotal Voting Rights
3rd Jun 201312:00 pmRNSTotal Voting Rights
22nd May 201311:00 amRNSAdditional Listing
7th May 20131:00 pmRNSDirector/PDMR Shareholding
7th May 20137:00 amRNSDirectorate Change
30th Apr 201311:00 amRNSTotal Voting Rights
25th Apr 20133:12 pmRNSResult of AGM
25th Apr 20137:00 amRNSAGM Statement
12th Apr 201311:00 amRNSDirector/PDMR Shareholding
3rd Apr 20134:10 pmRNSDirector/PDMR Shareholding
28th Mar 201311:30 amRNSTotal Voting Rights
25th Mar 201311:00 amRNSHolding(s) in Company
21st Mar 20139:30 amRNS2012 Annual Financial Report & Notice of 2013 AGM
6th Mar 201311:00 amRNSAdditional Listing
6th Mar 201311:00 amRNSHolding(s) in Company
6th Mar 201311:00 amRNSHolding(s) in Company
1st Mar 201311:00 amRNSBlocklisting Interim Review
28th Feb 201311:00 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSFinal Results
25th Feb 201311:00 amRNSHolding(s) in Company
20th Feb 20137:00 amRNSAcquisition
8th Feb 201311:00 amRNSDirector Declaration
1st Feb 201311:00 amRNSDirector/PDMR Shareholding
31st Jan 201311:00 amRNSTotal Voting Rights
24th Jan 201311:00 amRNSHolding(s) in Company
24th Jan 201311:00 amRNSHolding(s) in Company
17th Jan 201311:00 amRNSDirector/PDMR Shareholding
2nd Jan 201311:00 amRNSTotal Voting Rights
30th Nov 201211:00 amRNSTotal Voting Rights
7th Nov 201211:00 amRNSAdditional Listing
31st Oct 20121:00 pmRNSTotal Voting Rights
26th Oct 20127:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.